LINC01718

Across TCGA pan-cancer cohorts, LINC01718 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01718 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01718 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01718 expression acts as an unfavorable survival marker.

UCEC, STAD, and LUAD are the cancer types where LINC01718 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.054	0.592	<.001	90	view →
STAD	OS	Tertile	All	0.322	0.596	<.001	81	view →
LUAD	OS	Tertile	All	0.150	0.812	<.001	72	view →
HNSC	DFS	Tertile	All	0.090	0.714	<.001	69	view →
ACC	OS	Tertile	All	0.273	0.802	.017	45	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	42	view →
LAML	DFS	Tertile	All	0.140	0.575	.003	36	view →
SARC	DFS	Tertile	All	0.059	0.613	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01718–UCEC (OS)

Open the UCEC breakdown →